• Wed, November 16, 2016

by: WOPRAI

ProShares UltraPro QQQ (NASDAQ:TQQQ), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our

by: WOPRAI

Heritage - Crystal Clean Inc. (NASDAQ:HCCI), Up By $0.79 (5.33%) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, No

by: WOPRAI

Daxor Corp (NYSE:DXR), Up By $0.90 (11.08%) After BUYINS.NET SqueezeTrigger Report Released on Monday, November 14th 2016 at a

by: WOPRAI

Lakeland Financial Corporation (NASDAQ:LKFN), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined

by: WOPRAI

Huttig Building Products Inc. (NASDAQ:HBP), Up By $0.32 (6.42%) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, Nov

by: WOPRAI

Aduro Biotech Inc. (NASDAQ:ADRO), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our

by: WOPRAI

MCIG Inc. (OTC:MCIG), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

Vocera Communications Inc. (NYSE:VCRA), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined I

by: WOPRAI

Gevo Inc. (NASDAQ:GEVO), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

GREENGRO TECH (OTC:GRNH), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

WisdomTree India Earnings Fund ETF (NYSE:EPI), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Out

by: WOPRAI

Neptun SA (NASDAQ:NEPT), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

Alder BioPharmaceuticals (NASDAQ:ALDR), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined I

by: WOPRAI

Corcept Therapeutics Incorporated (NASDAQ:CORT), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions O

by: WOPRAI

GSE Systems, Inc. (NYSE:GVP) Down By 5.26% ($0.15) From $2.850 After BUYINS.NET Report Predicted Strength After Earnings

by: WOPRAI

Exelixis Inc. (NASDAQ:EXEL), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Repor

by: WOPRAI

USFD SqueezeTrigger Price is $23.93. There is $44,696,416 That Short Sellers Still Need To Cover.

by: WOPRAI

CIVB, ABTX, Expected to Trade Higher After Bullish Insider Trading

by: WOPRAI

ERI, CHSP, CDXS, CLGX, PAYC, SPKE, Expected to Trade Higher After Bullish Insider Trading

by: WOPRAI

CWT, BTN, CSU, JCS, BKSC, DDR, Expected to Trade Higher After Bullish Insider Trading

by: WOPRAI

COMM, KITE, PFNX, SHAK, ON, GATX, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

SAIA, TESO, GEVO, SAVE, CARB, RHP, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

DKL, RNST, ATRA, SATS, TNET, BAS, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

SFM, KSS, PX, PRU, ALGN, NBTB, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

JWN, PJC, GNCMA, SIGI, CORT, BGFV, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

SGEN, BMI, RGS, WDC, CSL, NUE, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

CMC, LNC, AXP, FDP, CHCO, MS, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

EUO, GAZ, AAV Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

QNST, UMDD, ST, MXL, RRTS, HAO Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

OSIR, SMCI, GXC, FXG, TREX, CIE Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

CENX, AIXG, GBDC, MSCI, SCMP, RPG Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

UL, ABG, ASRVP, SYNA, CLMS, CVI Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

FXI, EWP, ARTNA, MKSI, EZM, KTH Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

NUAN Expected To Be Up After Next Earnings Releases

by: WOPRAI

BKS Expected To Be Down Before Next Earnings Releases

by: WOPRAI

INTU, MATW Expected To Be Down After Next Earnings Releases

by: WOPRAI

David Risinger Downgraded (TEVA) to Hold and Decreased Target to $42 on, Nov 16th, 2016

by: WOPRAI

Tim Chiang Downgraded (TEVA) to Hold on, Nov 16th, 2016

by: WOPRAI

PT Luther Downgraded (SUM) to Hold on, Nov 16th, 2016

by: WOPRAI

Matthew Blair Upgraded (VLO) to Strong Buy on, Nov 16th, 2016

by: WOPRAI

Timna Tanners Downgraded (VMC) to Hold on, Nov 16th, 2016

by: WOPRAI

Will Slabaugh Downgraded (CAKE) to Hold on, Nov 16th, 2016

by: WOPRAI

Matthew Breese Downgraded (BHLB) to Hold on, Nov 16th, 2016

by: WOPRAI

Andrew Kuske Initiated (BBU) at Buy and Held Target at $29 on, Nov 16th, 2016

by: WOPRAI

Ken Zerbe Downgraded (ZION) to Hold on, Nov 16th, 2016

by: WOPRAI

James Picariello Downgraded (AXL) to Hold on, Nov 16th, 2016

by: WOPRAI

David George Downgraded (BAC) to Hold on, Nov 16th, 2016

by: WOPRAI

Kevin Barker Downgraded (USB) to Hold on, Nov 16th, 2016

Tim Chiang Downgraded (TEVA) to Hold on, Nov 16th, 2016

Tim Chiang of BTIG, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold on, Nov 16th, 2016.

Tim has made no other calls on TEVA in the last 4 months.



There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 3 agree with Tim's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Douglas Tsao of "Barclays" Initiated at Hold and Held Target at $46 on, Monday, November 14th, 2016
  • Sumant Kulkarni of "B of A Securities" Downgraded from Strong Buy to Hold on, Monday, November 7th, 2016
  • Irina Rivkind Koffler of "Mizuho" Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016


These are the ratings of the 3 analyists that currently disagree with Tim

  • Vamil Divan of "Credit Suisse" Upgraded from Hold to Buy on, Monday, October 31st, 2016
  • Derek Archila of "Oppenheimer" Upgraded from Hold to Buy on, Friday, September 2nd, 2016
  • Ami Fadia of "Leerink Swann" Maintained at Buy with Decreased Target to $61 on, Wednesday, August 31st, 2016